Decision-making in adult thalassemia patients undergoing unrelated bone marrow transplantation: Quality of life, communication and ethical issues

Bone Marrow Transplantation

Volumn 37, Issue 2, 2006, Pages 165-169

  Caocci, G ^a   Pisu, S ^b   Argiolu, F ^b   Giardini, C ^c   Locatelli, F ^d   Vacca, A ^a   Orofino, M G ^b   Piras, E ^a   De Stefano, P ^d   Addari, M C ^b   Ledda, A ^a   La Nasa, G ^a  

^a PO 'R Binaghi'   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c SAN SALVATORE HOSPITAL   (Italy)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Quality of life; Thalassemia; Unrelated donor bone marrow transplantation

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DOCTOR PATIENT RELATION; DONOR SELECTION; FEMALE; HLA MATCHING; HUMAN; INTERPERSONAL COMMUNICATION; MALE; MEDICAL DECISION MAKING; MEDICAL ETHICS; MORTALITY; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RISK ASSESSMENT; THALASSEMIA;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; CHOICE BEHAVIOR; DONOR SELECTION; FEMALE; HUMANS; LIVING DONORS; MALE; PHYSICIAN-PATIENT RELATIONS; QUALITY OF LIFE; QUESTIONNAIRES; RISK ASSESSMENT; THALASSEMIA;

EID: 30944447552     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705236     Document Type: Article

References (20)

1. Atkin K, Ahmad W. Living a 'normal life': Young people coping with thalassemia major or sickle cell disorder. Soc Sci Med 2001; 53: 615-626.
2. La Nasa G, Giardini C, Argiolu F, Locatelli F, Arras M, De Stefano P et al. Unrelated donor bone marrow transplantation for thalassemia: The effect of extended haplotypes. Blood 2002; 99: 4350-4356.
3. La Nasa G, Caocci G, Argiolu F, Giardini C, Locatelli F, Vacca A et al. Unrelated donor bone marrow transplantation in adult patients with thalassemia. Bone Marrow Transplant 2005; 36: 971-976.
4. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al. For the European Organization for Research and Treatment of Cancer. Study Group on Quality of Life. The EORTC QLQ-30: A quality of life instrument for use in international trials in oncology. J Natl Cancer Inst 1993; 85: 365-376.
5. Schofield PE, Butow PN, Thompson JF, Tattersall MHN, Beeney LJ, Dunn SM. Psychological responses of patients receiving a diagnosis of cancer. Ann Oncol 2003; 14: 48-56.
6. Sardell AN, Trierweiler SJ. Disclosing the cancer diagnosis. Procedures that influence patient hopefulness. Cancer 1997; 72: 3355-3365.
7. Ptacek JT, Eberhardt TL. The patient physician relationship. Breaking bad news: A review of the literature. JAMA 1996; 276: 492-496.
8. Rutter DR, Iconomou G, Quine L. Doctor-patient communication and outcome in cancer patients: An intervention. Psych Health 1996; 12: 57-71.
9. Epstein JB, Phillips N, Parry J, Epstein MS, Nevill T, Stevenson-Moore P. Quality of life, taste, olfactory and oral function following high-dose of chemotherapy and allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 2002; 30: 785-792.
10. Worel N, Biener D, Kalhs P, Mitterbauer M, Keil F, Schulenburg A et al. Long-term outcome and quality of life of patients who are alive and in complete remission more than two years after allogeneic and syngenic transplantation. Bone Marrow Transplant 2002; 30: 619-626.
11. Caro J, Ward A, Craig Green T, Huybrechts K, Arana A, Wait S et al. Impact of Thalassemia major on patients and their families. Acta Haematol 2002; 107: 150-157.
12. Arboretti R, Tognoni G, Alberti D. Pharmacosurveiliance and quality of care of thalassaemic patients. Eur J Clin Pharmacol 2001; 56: 915-922.
13. Hjermstad MJ, Holte H, Evensen SA, Fayers PM, Kaasa S. Do patients who are treated with stem cell transplantation have a health-related quality of fife comparable to the general population after 1 year? Bone Marrow Transplant 1999; 24: 911-918.
14. Hjermstad MJ, Loge JH, Evensen SA, Kvaloy SO, Fayers PM, Kaasa S. The course of anxiety and depression during the first year after allogenic or autologous stem cell transplantation. Bone Marrow Transplant 1999; 24: 1219-1228.
15. Zittoun R, Suciu S, Watson M, Solbu G, Muus P, Mandelli F et al. Quality of life in patients with acute myelogenous leukemia in prolonged first complete remission after bone marrow transplantation (allogeneic or autologous) or chemotherapy: A cross-sectional study of the EORTC-GIMEMA AML 8A trial. Bone Marrow Transplant 1997; 20: 307-315.
16. Sutherland HJ, Fyles GM, Adams G, Hao Y, Lipton JH, Minden MD et al. Quality of life following bone marrow transplantation: A comparison of patient reports with population norms. Bone Marrow Transplant 1997; 19: 1129-1136.
17. Zecca M, Prete A, Rondelli R, Lanino E, Balduzzi A, Messina C et al. Chronic graft-versus-host disease in children: Incidence, risk factors, and impact on outcome. Blood 2002; 100: 1192-1200.
18. Beauchamp TL, Childress JF (eds). Principles of Biomedical Ethics. Oxford University Press: New York, NY, 1994, 190 pp.
19. Pellegrino E. Humanistic base for professional ethics in medicine. New York State J Med 1997; 77: 1456-1462.
20. Engel E. The clinical application of the biopsychosocial model. Am J Psychiatry 1980; 137: 535-544.